Qiaodan Zhou

1.3k total citations · 1 hit paper
21 papers, 815 citations indexed

About

Qiaodan Zhou is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Qiaodan Zhou has authored 21 papers receiving a total of 815 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Oncology. Recurrent topics in Qiaodan Zhou's work include Liver physiology and pathology (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Qiaodan Zhou is often cited by papers focused on Liver physiology and pathology (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Qiaodan Zhou collaborates with scholars based in China, United States and Hong Kong. Qiaodan Zhou's co-authors include Jianyou Shi, Rongsheng Tong, Zhongliang Jiang, Cheng Peng, Haiying Lu, Jun He, Wei Zhang, Lin Chen, Huifang Liang and Lin Chen and has published in prestigious journals such as International Journal of Molecular Sciences, Frontiers in Immunology and Advanced Science.

In The Last Decade

Qiaodan Zhou

20 papers receiving 807 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials

2020 537 citations Haiying Lu, Qiaodan Zhou et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Qiaodan Zhou

Since Specialization

Citations

This map shows the geographic impact of Qiaodan Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiaodan Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiaodan Zhou more than expected).

Fields of papers citing papers by Qiaodan Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiaodan Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiaodan Zhou. The network helps show where Qiaodan Zhou may publish in the future.

Co-authorship network of co-authors of Qiaodan Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Qiaodan Zhou. A scholar is included among the top collaborators of Qiaodan Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiaodan Zhou. Qiaodan Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Oncofetal dual‑specificity phosphatase 9 drives stem‐like properties through ERK1/2‐PPARG‐SCD axis‐mediated lipid metabolism in hepatocellular carcinoma 2025 ·Clinical and Translational Medicine ·Peng Wang, Hai Huang, Yuchong Zhao, Qiaodan Zhou, (unknown), Luyao Liu, Jingwen Liang, (unknown), (unknown), Wei Chen, Si Xiong, Bin Cheng, Shuya Bai	0
2	PPY‐Induced iCAFs Cultivate an Immunosuppressive Microenvironment in Pancreatic Cancer 2025 ·Advanced Science ·(unknown), Peng Wang, Bin Cheng, Ronghua Wang, (unknown), Luyao Liu, Hai Huang, (unknown), (unknown), Jingwen Liang, Qiaodan Zhou, Si Xiong, Shuya Bai, (unknown), Yuchong Zhao	1
3	Senescent fibroblasts secrete CTHRC1 to promote cancer stemness in hepatocellular carcinoma 2025 ·Cell Communication and Signaling ·Hai Huang, Peng Wang, Qiaodan Zhou, Yuchong Zhao, Luyao Liu, (unknown), Jingwen Liang, (unknown), Wei Chen, Ronghua Wang, (unknown), Si Xiong, Bin Cheng, Shuya Bai	3
4	The cancer-associated fibroblast facilitates YAP liquid-liquid phase separation to promote cancer cell stemness in HCC 2025 ·Cell Communication and Signaling ·Wei Chen, Yanling Li, Qiaodan Zhou, Peng Wang, (unknown), Yuchong Zhao, (unknown), Si Xiong, Hai Huang, Luyao Liu, Shuya Bai, Bin Cheng	4
5	Anti-CTGF/PD-1 bispecific antibody Y126S restrains desmoplastic and immunosuppressive microenvironment in pancreatic cancer 2025 ·Journal for ImmunoTherapy of Cancer ·(unknown), Yuchong Zhao, (unknown), Peng Wang, Hai Huang, Yilei Yang, Jingwen Liang, Wei Chen, Shuya Bai, Qiaodan Zhou, Jiamei Jiang, (unknown), Ronghua Wang, Bin Cheng	2
6	CTNNB1 Alternation Is a Potential Biomarker for Immunotherapy Prognosis in Patients With Hepatocellular Carcinoma 2021 ·Frontiers in Immunology ·Lin Chen, Qiaodan Zhou, (unknown), Wei Zhang	49
7	Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy 2021 ·Frontiers in Pharmacology ·Wenjing Xiao, Qiaodan Zhou, Xudong Wen, Rui Wang, Ruijie Liu, Tingting Wang, Jianyou Shi, Yonghe Hu, Jun Hou	26
8	Drugs for the treatment of glaucoma: Targets, structure-activity relationships and clinical research 2021 ·European Journal of Medicinal Chemistry ·Xianbo Wu, Xinwei Yang, Qi Liang, (unknown), (unknown), (unknown), (unknown), Rongsheng Tong, (unknown), Qiaodan Zhou, Jianyou Shi	11
9	Protective Effects of PGC-1α on the Blood Brain Barrier After Acute Kidney Injury 2020 ·Neurochemical Research ·Hao Pan, Junhua Li, Qiaodan Zhou, Fengming Zhu, Siyuan He	8
10	Recent advances in the development of protein–protein interactions modulators: mechanisms and clinical trials breakdown → 2020 ·Signal Transduction and Targeted Therapy ·Haiying Lu, Qiaodan Zhou, Jun He, Zhongliang Jiang, Cheng Peng, Rongsheng Tong, Jianyou Shi	537
11	Ultrasound-guided needle release of the transverse carpal ligament with and without corticosteroid injection for the treatment of carpal tunnel syndrome 2018 ·Journal of Orthopaedic Surgery and Research ·(unknown), (unknown), Man Lu, Xueqing Cheng, (unknown), Shiyin Chen, Kai Chen, Qiaodan Zhou, Lei Wang, (unknown), (unknown), (unknown), Qin Chen	13
12	Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice 2016 ·Journal of Huazhong University of Science and Technology [Medical Sciences] ·Ying Zhang, Jin Wang, Qiaodan Zhou, Conghui Zhang, Qing Li, Shuai Huang, Juan Zhan, Kun Wang, Yanyan Liu, Gang Xu	5
13	Cdc42-Interacting Protein 4 Represses E-Cadherin Expression by Promoting β-Catenin Translocation to the Nucleus in Murine Renal Tubular Epithelial Cells 2015 ·International Journal of Molecular Sciences ·Chuou Xu, Qiaodan Zhou, Lili Liu, Ping Liu, Guangchang Pei, Rui Zeng, Min Ho Han, Gang Xu	7
14	Kallikrein expression as a prognostic factor in ovarian cancer: a systematic review and meta-analysis. 2015 ·PubMed ·(unknown), (unknown), Qiaodan Zhou	4
15	Activin A induces growth arrest through a SMAD- dependent pathway in hepatic progenitor cells 2014 ·Cell Communication and Signaling ·Lin Chen, Wei Zhang, Huifang Liang, Qiaodan Zhou, Zeyang Ding, (unknown), Weibo Liu, Yanhui Wu, (unknown), Bixiang Zhang, Xiaoping Chen	32
16	Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells 2013 ·Journal of Huazhong University of Science and Technology [Medical Sciences] ·Qiaodan Zhou, Yong Ning, Rui Zeng, Lin Chen, (unknown), Chuou Xu, Guangchang Pei, Min Ho Han, Gang Xu	8
17	Cdc42-Interacting Protein-4 Promotes TGF-Β1-Induced Epithelial-Mesenchymal Transition and Extracellular Matrix Deposition in Renal Proximal Tubular Epithelial Cells 2012 ·International Journal of Biological Sciences ·Shoujun Bai, Rui Zeng, Qiaodan Zhou, Wenhui Liao, Yamin Zhang, Chuou Xu, Min Ho Han, Guangchang Pei, Lili Liu, Xiaocheng Liu, (unknown), Gang Xu	23
18	HSCs play a distinct role in different phases of oval cell‐mediated liver regeneration 2012 ·Cell Biochemistry and Function ·Lin Chen, Wei Zhang, Qiaodan Zhou, (unknown), Huifang Liang, (unknown), Xin Long, Xiaoping Chen	36
19	Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway 2011 ·Journal of Molecular Medicine ·Qiaodan Zhou, Rui Zeng, Chuou Xu, Lili Liu, Lin Chen, (unknown), Guangchang Pei, Shoujun Bai, Yamin Zhang, Caixia Li, Song Rong, Min Ho Han, Gang Xu	29
20	[Differentiation of hepatic oval cell into mature hepatocyte induced by hepatic stellate cells]. 2009 ·PubMed ·(unknown), Xiaoping Chen, Wei Zhang, Huifang Liang, (unknown), Hanhua Dong, Qiaodan Zhou	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact